IGF2BP2 and prostate carcinoma: Studies have shown that EIF4A3‐IGF2BP2 is an important pathway in prostate cancer,38 suggesting that the EIF4A3‐circDHTKD1‐IGF2BP2‐PFKL axis may have a potential function in other cancers, which warrants further investigation.